ID
18999
Description
Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00241475
Link
https://clinicaltrials.gov/show/NCT00241475
Keywords
Versions (1)
- 11/29/16 11/29/16 -
Uploaded on
November 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT00241475
Eligibility Prostate Cancer NCT00241475
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Neoplasm Metastasis
Data type
boolean
Alias
- UMLS CUI [1]
- C0027627
Description
Hormone Therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0279025
Description
Therapeutic radiology procedure | Operative Surgical Procedures | Chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C1522449
- UMLS CUI [2]
- C0543467
- UMLS CUI [3]
- C0392920
Description
Lung Diseases, Interstitial
Data type
boolean
Alias
- UMLS CUI [1]
- C0206062
Similar models
Eligibility Prostate Cancer NCT00241475
- StudyEvent: Eligibility
C1522449 (UMLS CUI [2])
C0278838 (UMLS CUI [3])
C1513916 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0392920 (UMLS CUI [3])